In this context, genome wide association studies (GWAS) have associated the LRRK2 locus and IBD, and some functional variants of LRRK2 increase the risk for both CD and PD, such as the G2019S and N2081D [28, 34, 39]. This evidence concerns the gene LRRK2 and inflammatory bowel disease.